financetom
Business
financetom
/
Business
/
Applied Materials Issues Downbeat Quarterly Revenue Outlook as China Trade Restrictions Weigh
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Applied Materials Issues Downbeat Quarterly Revenue Outlook as China Trade Restrictions Weigh
Feb 14, 2025 3:53 AM

06:39 AM EST, 02/14/2025 (MT Newswires) -- Applied Materials ( AMAT ) shares fell early Friday as the company issued a downbeat fiscal second-quarter revenue outlook at the midpoint amid the impact of US restrictions on exports to China, while the semiconductor equipment manufacturer recorded better-than-expected results in the preceding three-month period.

The company anticipates revenue to come in at $7.1 billion, plus or minus $400 million, for the ongoing quarter, it said late Thursday. The current consensus on FactSet is for sales of $7.16 billion. Adjusted earnings are pegged at $2.30 a share for the second quarter, plus or minus $0.18, while the Street is looking for $2.30.

"The ability of US companies to serve the China market is constrained and has been further limited by updated trade rules announced in December and January," Chief Executive Gary Dickerson said during an earnings call, according to a FactSet transcript. The company expects to face a revenue headwind of about $400 million in fiscal 2025 as a result of the expanded export controls, with "nearly half" of the impact to be incurred in the second quarter, Chief Financial Officer Brice Hill said on the call.

Earlier in February, US President Donald Trump imposed a 10% levy on imports from China, which announced its own retaliatory tariffs against the country.

China was Applied Materials' ( AMAT ) largest market by revenue share in the first quarter, but saw its contribution drop to 31% of overall revenue from 45%in the prior-year quarter. "For (the second quarter) we expect that China as a percentage of total revenue will be about 5 percentage points lower than in (the first quarter)," Hill said. "This is below the normalized level of approximately 30%."

The stock declined 5% in premarket activity.

The impact of trade restrictions is expected to be "more weighted" to the company's applied global services segment in the second half of the fiscal year, Hill told analysts. The company expects the division to return to growth in the third quarter, the CFO added.

"While our near-term service growth is negatively impacted by trade restrictions, we remain confident that we will still grow (applied global services) at a low-double digit annualized growth rate over the longer term," Dickerson said on the call.

For the three months through Jan. 26, adjusted EPS increased 12% year over year to $2.38, topping the average analyst estimate of $2.28. Revenue improved to $7.17 billion from $6.71 billion last year, ahead of the market's forecast of $7.15 billion.

Sales in the semiconductor systems segment rose to $5.36 billion from $4.91 billion, while applied global services advanced to $1.59 billion from $1.48 billion. Display revenue declined to $183 million from $244 million last year, according to the company.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Copyright 2023-2026 - www.financetom.com All Rights Reserved